Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/24 18:52 | 12/13/24 | OLMA | Health | Drug | Pharmaceutical Preparations | Graham G. Walmsley | CA | D | 4 | S | -44,358 | 11.82 | 0 | -3,752 | 1,409 | I | ||||||||||||||||
12/11/24 19:56 | 12/10/24 | OLMA | Health | Drug | Pharmaceutical Preparations | Harmon Cyrus | CA | D | 14 | S.m | -3,016 | 11.85 | 0 | -255 | 1,073 | D | ||||||||||||||||
12/11/24 19:56 | 12/10/24 | OLMA | Health | Drug | Pharmaceutical Preparations | Myles David C. | CA | O | CH. DISC | 4 | S.m | -595 | 11.81 | 0 | -50 | 766 | D | |||||||||||||||
12/11/24 19:54 | 12/10/24 | OLMA | Health | Drug | Pharmaceutical Preparations | Zojwalla Naseem | CA | O | CHIEF ME | 2 | S.m | -460 | 10.85 | 0 | -42 | 116 | D | |||||||||||||||
12/11/24 19:53 | 12/10/24 | OLMA | Health | Drug | Pharmaceutical Preparations | Kovacs Shane William Charles | CA | O | CH. OPER | 2 | S.m | -586 | 10.88 | 0 | -54 | 544 | D | |||||||||||||||
12/11/24 19:52 | 12/10/24 | OLMA | Health | Drug | Pharmaceutical Preparations | Bohen Sean | CA | DO | P,CEO | 2 | S.m | -1,810 | 10.86 | 0 | -167 | 242 | D | |||||||||||||||
8/5/24 16:30 | 8/1/24 | OLMA | Health | Drug | Pharmaceutical Preparations | Paradigm Biocapital Advisors LP | NY | T | 1 | S | -35,796 | 14.92 | 0 | -2,400 | 5,504 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |